Cutler Group LP Bicycle Therapeutics PLC Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Jul 18, 2023	BUY	$18.95 - $28.67 $7,580 - $11,468	400 Added 100.0%	800 $0
Q1 2023 May 01, 2023	BUY	$20.02 - $31.37 $8,008 - $12,548	400 New	400 $0
Q2 2022 Aug 04, 2022	SELL	$12.95 - $46.99 $129,500 - $469,900	-10,000 Reduced 99.01%	100 $0
Q1 2022 Apr 14, 2022	BUY	$40.12 - $59.5 $405,212 - $600,950	10,100 New	10,100 $2,000

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $436M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.